|
25
|
109
|
5l8lB |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 1) |
|
24
|
105
|
5l8jB |
Aurora-a kinase domain in complex with vnar-d01 s93r |
|
28
|
114
|
5lveA |
Structure of the variable domain of human immunoglobulin k-4 light chain len |
|
25
|
105
|
5l8kB |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 2) |
|
45
|
222
|
6iscA |
Complex structure of mcd226-ecto and hcd155-d1 |
|
58
|
240
|
5ks9F |
Bel502-dq8-glia-alpha1 complex |
|
43
|
200
|
5ksbE |
T15-dq8.5-glia-gamma1 complex |
|
42
|
195
|
5ksaC |
Bel602-dq8.5-glia-gamma1 complex |
|
47
|
221
|
6isbA |
Crystal structure of human cd226 |
|
17
|
113
|
5jxeA |
Human pd-1 ectodomain complexed with pembrolizumab fab |
|
28
|
127
|
5j89A |
Structure of human programmed cell death 1 ligand 1 (pd-l1) with low molecular mass inhibitor |
|
39
|
209
|
5jdrA |
Structure of pd-l1 |
|
26
|
122
|
5j8oA |
Structure of human programmed cell death 1 ligand 1 (pd-l1) with low molecular mass inhibitor |
|
48
|
213
|
5j0bA |
Structure of the immune receptor cd33 in complex with 6'-sialyllactose |
|
48
|
213
|
5j06A |
Structure of the immune receptor cd33 in complex with 3'-sialyllactose |
|
23
|
119
|
5iusA |
Crystal structure of human pd-l1 in complex with high affinity pd-1 mutant |
|
27
|
119
|
5imlA |
Nanobody targeting human vsig4 in spacegroup p212121 |
|
46
|
213
|
5ijvA |
Crystal structure of bovine fab e03 |
|
49
|
213
|
5ihbA |
Structure of the immune receptor cd33 |
|
24
|
120
|
5immA |
Nanobody targeting mouse vsig4 in spacegroup p212121 |
|
45
|
213
|
5ihuL |
Crystal structure of bovine fab b11 |
|
48
|
246
|
5hyjE |
1e6 tcr in complex with hla-a02 carrying aqwgpdpaaa |
|
28
|
113
|
5fflA |
Crystal structure of mouse cd300lf at 1.6 angstroms resolution. |
|
32
|
122
|
5febA |
Crystal structure of the voltage-gated sodium channel beta 2 subunit extracellular domain |
|
44
|
217
|
7fabH |
Crystal structure of human immunoglobulin fragment fab new refined at 2.0 angstroms resolution |
|
29
|
108
|
6gbhB |
Helicobacter pylori adhesin hopq type ii bound to the n-terminal domain of human ceacam1 |
|
30
|
110
|
6gbgD |
Helicobacter pylori adhesin hopq type i bound to the n-terminal domain of human ceacam1 |
|
27
|
109
|
6e47F |
Crystal structure of the murine norovirus vp1 p domain in complex with the cd300lf receptor and glycochenodeoxycholic acid |
|
28
|
113
|
6e48F |
Crystal structure of the murine norovirus vp1 p domain in complex with the cd300lf receptor and lithocholic acid |
|
37
|
200
|
6cqlD |
Crystal structure of f24 tcr -dr11-rq13 peptide complex |
|
37
|
200
|
6cqqD |
Crystal structure of f24 tcr -dr15-rq13 peptide complex |
|
40
|
200
|
6cphD |
Crystal structure of the f24 tcr |
|
36
|
200
|
6cqnD |
Crystal structure of f5 tcr -dr11-rq13 peptide complex |
|
33
|
200
|
6cqrD |
Crystal structure of f24 tcr -dr1-rq13 peptide complex |
|
28
|
111
|
6c74A |
Crystal structure of murine cd300lf in complex with phosphocholine |
|
30
|
109
|
6c6qD |
Crystal structure of the murine norovirus vp1 p domain in complex with the cd300lf receptor |
|
22
|
115
|
6bitG |
Sirpalpha antibody complex |
|
25
|
109
|
6b8oA |
Wt ig-like v domain with phosphatidylserine |
|
25
|
108
|
6avzA |
Crystal structure of the hopq-ceacam3 wt complex |
|
25
|
108
|
6aw0A |
Crystal structure of ceacam3 l44q |
|
23
|
108
|
6aw3A |
Crystal structure of the hopq-ceacam3 l44q complex |
|
23
|
108
|
6aw1A |
Crystal structure of ceacam3 |
|
27
|
107
|
6aw2A |
Crystal structure of the hopq-ceacam1 complex |
|
16
|
104
|
5z11A |
Crystal structure of grass carp cd8 alpha alpha homodimers |
|
59
|
250
|
5yd3A |
Crystal structure of the scfv antibody 4b08 with epitope peptide |
|
58
|
251
|
5yd4A |
Crystal structure of the scfv antibody 4b08 with epitope peptide (mutation t6a) |
|
61
|
251
|
5yd5A |
Crystal structure of the scfv antibody 4b08 with epitope peptide (mutation n3a) |
|
30
|
119
|
5xofA |
Crystal structure of human paired immunoglobulin-like type 2 receptor alpha with synthesized glycopeptide i |
|
43
|
213
|
5w1kC |
Junv gp1 cr1-10 fab cr1-28 fab complex |
|
20
|
116
|
5x8lA |
Pd-l1 in complex with atezolizumab |
